Ireland-based Medtronic plc (NYSE:MDT) has named Sean Salmon as its executive vice president and president, Cardiovascular Portfolio, effective January 1, 2021, it was reported on Monday.

Presently, Salmon is the executive vice president and president, Diabetes Operating Unit and will continue to lead the Diabetes Operating Unit and serve on the firm's Executive Committee. He has spent 15 years in roles of increasing responsibility within Cardiovascular, including leading the Coronary and Renal Denervation, Peripheral, Cardiac Surgery, and Structural Heart businesses.

Salmon will continue in his role heading the Diabetes turnaround and his role working closely with the other portfolio leaders and members of the Executive Committee on enterprise-level strategy and value creation under Medtronic's new operating model.